1. Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!

   • Florian Lemaitre

   Editorial 23 July 2022 Pages: 1071 - 1073

   

2. Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

   • Caspar J. Hodiamont
   • Annemieke K. van den Broek
   • Reinier M. van Hest

   Review Article Open access 27 June 2022 Pages: 1075 - 1094

   

3. Clinical Pharmacokinetics of Metoprolol: A Systematic Review

   • Ammara Zamir
   • Iltaf Hussain
   • Muhammad Fawad Rasool

   Systematic Review 28 June 2022 Pages: 1095 - 1114

   

4. Prediction of Drug–Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model

   • Marie-Emilie Willemin
   • Peter Zannikos
   • Jan Snoeys

   Original Research Article 17 May 2022 Pages: 1115 - 1128

   

5. Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments

   • V. E. Bukkems
   • H. van Hove
   • A. Colbers

   Original Research Article Open access 17 May 2022 Pages: 1129 - 1141

   

6. Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study

   • Christian Friedrich
   • Klaus Francke
   • Alyn Morice

   Original Research Article Open access 28 May 2022 Pages: 1143 - 1156

   

7. A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation

   • Alexandre Destere
   • Pierre Marquet
   • Jean-Baptiste Woillard

   Original Research Article 31 May 2022 Pages: 1157 - 1165

   

8. Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study

   • Koen P. van Rhee
   • Cornelis Smit
   • Catherijne A. J. Knibbe

   Original Research Article Open access 01 June 2022 Pages: 1167 - 1175

   

9. Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline

   • Lénaïg Tanneau
   • Mats O. Karlsson
   • Elin M. Svensson

   Original Research Article Open access 07 June 2022 Pages: 1177 - 1185

   

10. Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance

    • Chanan Shaul
    • Simcha Blotnick
    • Yoseph Caraco

    Original Research Article 14 June 2022 Pages: 1187 - 1198